Access cutting-edge t-cell lymphoblastic leukemia treatment through this clinical trial at a research site in Kingman. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Kingman location
Access t-cell lymphoblastic leukemia specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related t-cell lymphoblastic leukemia treatment provided free
Check if you qualify for this t-cell lymphoblastic leukemia clinical trial in Kingman, AZ
No-Cost Study Care
Local to Kingman
Convenient for AZ residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This phase I/II trial studies the safety, side effects and best dose of OBI-3424 and how well it works in treating patients with T-cell acute lymphoblastic leukemia or T-cell lymphoblastic lymphoma that has come back (relapsed) or does not respond to treatment (refractory). Chemotherapy drugs, such as OBI-3424, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. OBI-3424 may reduce the amount
Sponsor: SWOG Cancer Research Network
Yes, this clinical trial (NCT04315324) has an active research site in Kingman, AZ that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for t-cell lymphoblastic leukemia treatment options in Kingman, AZ, this clinical trial (NCT04315324) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Kingman research site is actively enrolling participants for this clinical trial. You'll receive care from experienced t-cell lymphoblastic leukemia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all t-cell lymphoblastic leukemia clinical trials near you to find additional studies recruiting in your area.
See all leukemia clinical trials recruiting in Kingman — not just this study.
Browse Leukemia Trials in Kingman →